Drug Trial Radar · NCT03539952
Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
Last checked: Nov 19, 2026Latest source record: Jul 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
77
Actual
Start
Sep 3, 2018
Primary completion
Aug 19, 2020
Study completion Jan 18, 2022
Sponsor
- Lead sponsor
- OrphalanIndustry
- Sponsor type
- Industry
- First posted
- May 30, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, open-label study with an active standard-of-care comparator (penicillamine)
Conditions
- Wilson Disease
Interventions
Penicillamine (D1-W12)Drug
Penicillamine during baseline period (D1-W12)
TETA 4HCL (W12-60)Drug
TETA 4HCL during post randomisation and 1st extension period (W12-W60)
Penicillamine (W12-W60)Drug
Penicillamine during rondomisation and 1st extension period period (W12-W60)
TETA 4HCL (60-<W108)Drug
TETA 4HCL during 2nd extension period (W60-\<W108)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serum NCC ConcentrationTime frame: Week 36
Locations
15 sites in 9 countries. Site status is shown where the registry gives one.
Yale University School of Medicine
New Haven, Connecticut
KU Leuven, Department of Clinical and Experimental Medicine
Leuven, Belgium
Hospital Nossa Senhora das Graças (HNSG)
Curitiba, Brazil
Nucleo de Pesquisa e Desenvolvimento de Medicamentos - Universidade Federal do Ceará - Rodolfo Teófilo
Fortaleza, Brazil
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
São Paulo, Brazil
Hepato-gastroenterologisk afd
Aarhus, Denmark
Hospital mother children
Bron, France
Centre National de Référence Wilson, Hôpital Lariboisière
Paris, France
Innere Medizin
Heidelberg, Germany
Poliklinik Hepatologie/Transplantationsambulanz
Munich, Germany
A.O. San Paolo Milano
Milan, Italy
DiSCOG Gastroenterology Unit
Padova, Italy
Institute of Psychiatry and Neurology
Warsaw, Poland
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
University of Surrey, Department of Clinical and Experimental Medicine
Guildford, Surrey, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.